Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Liver Diseases

Free Subscription Articles published in Cancer Res Retrieve available abstracts of 49 articles: HTML format

Single Articles

November 2021
1. PEASE DR, Fernandez-Zapico ME
   mTOR-Dependent ARID1A Degradation: A New Twist in the Genetic-Epigenetic Interplay Driving Hepatocellular Carcinoma.
   Cancer Res. 2021;81:5608-5610.
   PubMed     Abstract available
   
   
   
2. REN X, Rong Z, Liu X, Gao J, et al
   The protein kinase activity of NME7 activates Wnt/beta-Catenin signaling to promote one-carbon metabolism in hepatocellular carcinoma.
   Cancer Res. 2021 Nov 11. pii: 0008-5472.CAN-21-1020.
   PubMed     Abstract available
   
   
   October 2021
3. BARCENA-VARELA M, Lujambio A
   A Novel Long Noncoding RNA Finetunes the DNA Damage Response in Hepatocellular Carcinoma.
   Cancer Res. 2021;81:4899-4900.
   PubMed     Abstract available
   
   
   September 2021
4. LOH JJ, Li TW, Zhou L, Wong TL, et al
   FSTL1 secreted by activated fibroblasts promotes hepatocellular carcinoma metastasis and stemness.
   Cancer Res. 2021 Sep 22. pii: 0008-5472.CAN-20-4226.
   PubMed     Abstract available
   
   
   August 2021
5. ZHANG S, Zhou YF, Cao J, Burley SK, et al
   mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
   Cancer Res. 2021 Aug 24. pii: 0008-5472.CAN-21-0206.
   PubMed     Abstract available
   
   
   July 2021
6. UNFRIED JP, Marin-Baquero M, Rivera-Calzada A, Razquin N, et al
   Long noncoding RNA NIHCOLE promotes ligation efficiency of DNA double-strand breaks in hepatocellular carcinoma.
   Cancer Res. 2021 Jul 28. pii: 0008-5472.CAN-21-0463.
   PubMed     Abstract available
   
   
   
7. QIU X, Yang S, Wang S, Wu J, et al
   M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.
   Cancer Res. 2021 Jul 23. pii: 0008-5472.CAN-21-0468.
   PubMed     Abstract available
   
   
   June 2021
8. SHRIKI A, Lanton T, Sonnenblick A, Levkovitch-Siany O, et al
   Multiple Roles of IL-6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis.
   Cancer Res. 2021 Jun 11. pii: 0008-5472.CAN-21-0321.
   PubMed     Abstract available
   
   
   
9. GONZALEZ-ROMERO F, Mestre D, Aurrekoetxea I, O'Rourke CJ, et al
   E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
   Cancer Res. 2021;81:2874-2887.
   PubMed     Abstract available
   
   
   
10. LULLI M, Del Coco L, Mello T, Sukowati C, et al
    DNA Damage Response Protein CHK2 Regulates Metabolism in Liver Cancer.
    Cancer Res. 2021;81:2861-2873.
    PubMed     Abstract available
    
    
    May 2021
11. ZHAO Z, Gad H, Benitez-Buelga C, Sanjiv K, et al
    NEIL3 prevents senescence in hepatocellular carcinoma by repairing oxidative lesions at telomeres during mitosis.
    Cancer Res. 2021 May 27. pii: 0008-5472.CAN-20-1028.
    PubMed     Abstract available
    
    
    
12. MA APY, Yeung CLS, Tey SK, Mao X, et al
    Suppression of ACADM-mediated fatty acid oxidation promotes hepatocellular carcinoma via aberrant Cav1/SREBP-1 signaling.
    Cancer Res. 2021 May 11. pii: 0008-5472.CAN-20-3944.
    PubMed     Abstract available
    
    
    April 2021
13. LEUNG HW, Leung CO, Lau EY, Chung KPS, et al
    EPHB2 activates beta-catenin to enhance cancer stem cell properties and drive sorafenib resistance in hepatocellular carcinoma.
    Cancer Res. 2021 Apr 26. pii: 0008-5472.CAN-21-0184.
    PubMed     Abstract available
    
    
    
14. DU L, Li Y, Kang M, Feng M, et al
    USP48 is upregulated by Mettl14 to attenuate hepatocellular carcinoma via regulating SIRT6 stabilization.
    Cancer Res. 2021 Apr 26. pii: 0008-5472.CAN-20-4163.
    PubMed     Abstract available
    
    
    
15. RICCIOTTI E, Wangensteen KJ, FitzGerald GA
    Aspirin in hepatocellular carcinoma.
    Cancer Res. 2021 Apr 23. pii: 0008-5472.CAN-21-0758.
    PubMed     Abstract available
    
    
    
16. FUHRMAN BJ, Moore SC, Byrne C, Makhoul I, et al
    Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts.
    Cancer Res. 2021;81:2246-2255.
    PubMed     Abstract available
    
    
    
17. BROADFIELD LA, Duarte JAG, Schmieder R, Broekaert D, et al
    Fat Induces Glucose Metabolism in Nontransformed Liver Cells and Promotes Liver Tumorigenesis.
    Cancer Res. 2021;81:1988-2001.
    PubMed     Abstract available
    
    
    March 2021
18. ZHANG C, Gao Y, Du C, Markowitz GJ, et al
    Hepatitis B-induced IL-8 Promotes Hepatocellular Carcinoma Venous Metastasis and Intrahepatic Treg Accumulation.
    Cancer Res. 2021 Mar 2. pii: 0008-5472.CAN-20-3453.
    PubMed     Abstract available
    
    
    February 2021
19. MENG Y, Zhao Q, An L, Jiao S, et al
    A TNFR2-hnRNPK axis promotes primary liver cancer development via activation of YAP signaling in hepatic progenitor cells.
    Cancer Res. 2021 Feb 22. pii: 0008-5472.CAN-20-3175.
    PubMed     Abstract available
    
    
    
20. BI L, Ren Y, Feng M, Meng P, et al
    HDAC11 regulates glycolysis through the LKB1/AMPK signaling pathway to maintain hepatocellular carcinoma stemness.
    Cancer Res. 2021 Feb 18. pii: 0008-5472.CAN-20-3044.
    PubMed     Abstract available
    
    
    
21. ZHOU J, Li Q, Cao Y
    Spatiotemporal Heterogeneity Across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer.
    Cancer Res. 2021 Feb 15. pii: 0008-5472.CAN-20-3665.
    PubMed     Abstract available
    
    
    
22. DAVENPORT ML, Echols JB, Silva AD, Anderson JC, et al
    miR-31 displays subtype specificity in lung cancer.
    Cancer Res. 2021 Feb 8. pii: 0008-5472.CAN-20-2769.
    PubMed     Abstract available
    
    
    January 2021
23. YAMADA K, Oikawa T, Kizawa R, Motohashi S, et al
    Unconventional Secretion of PKCdelta Exerts Tumorigenic Function via Stimulation of ERK1/2 Signaling in Liver Cancer.
    Cancer Res. 2021;81:414-425.
    PubMed     Abstract available
    
    
    
24. HONG SH, Son KH, Ha SY, Wee TI, et al
    Nucleoporin 210 Serves a Key Scaffold for SMARCB1 in Liver Cancer.
    Cancer Res. 2021;81:356-370.
    PubMed     Abstract available
    
    
    
25. GENG Y, Fan J, Chen L, Zhang C, et al
    A Notch-Dependent Inflammatory Feedback Circuit between Macrophages and Cancer Cells Regulates Pancreatic Cancer Metastasis.
    Cancer Res. 2021;81:64-76.
    PubMed     Abstract available
    
    
    
26. BATTISTELLI C, Garbo S, Riccioni V, Montaldo C, et al
    Design and Functional Validation of a Mutant Variant of the LncRNA HOTAIR to Counteract Snail Function in Epithelial-to-Mesenchymal Transition.
    Cancer Res. 2021;81:103-113.
    PubMed     Abstract available
    
    
    December 2020
27. CAI LY, Chen SJ, Xiao SH, Sun QJ, et al
    Targeting p300/CBP attenuates hepatocellular carcinoma progression through epigenetic regulation of metabolism.
    Cancer Res. 2020 Dec 23. pii: 0008-5472.CAN-20-1323.
    PubMed     Abstract available
    
    
    
28. ZHOU Q, Tian W, Jiang Z, Huang T, et al
    A positive feedback loop of AKR1C3-mediated activation of NF-kappaB and STAT3 facilitates proliferation and metastasis in hepatocellular carcinoma.
    Cancer Res. 2020 Dec 23. pii: 0008-5472.CAN-20-2480.
    PubMed     Abstract available
    
    
    
29. FEI F, Sun S, Li Q, Pei Z, et al
    Combinatorial normalization of liver-derived cytokine pathways alleviates hepatic tumor-associated cachexia in zebrafish.
    Cancer Res. 2020 Dec 21. pii: 0008-5472.CAN-20-2818.
    PubMed     Abstract available
    
    
    
30. THOMANN S, Weiler SME, Marquard S, Rose F, et al
    YAP Orchestrates Heterotypic Endothelial Cell Communication via HGF/c-MET Signaling in Liver Tumorigenesis.
    Cancer Res. 2020;80:5502-5514.
    PubMed     Abstract available
    
    
    October 2020
31. WILLS CA, Liu X, Chen L, Zhao Y, et al
    Chemotherapy-Induced Upregulation of Small Extracellular Vesicle-Associated PTX3 Accelerates Breast Cancer Metastasis.
    Cancer Res. 2020 Oct 28. pii: 0008-5472.CAN-20-1976.
    PubMed     Abstract available
    
    
    
32. MATSUMORI T, Kodama Y, Takai A, Shiokawa M, et al
    Hes1 is essential in proliferating ductal cell-mediated development of intrahepatic cholangiocarcinoma.
    Cancer Res. 2020 Oct 16. pii: 0008-5472.CAN-20-1161.
    PubMed     Abstract available
    
    
    
33. MORITA T, Kodama Y, Shiokawa M, Kuriyama K, et al
    CXCR4 in Tumor Epithelial Cells Mediates Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma.
    Cancer Res. 2020;80:4058-4070.
    PubMed     Abstract available
    
    
    August 2020
34. UROSEVIC J, Blasco MT, Llorente A, Bellmunt A, et al
    ERK1/2 signaling induces upregulation of ANGPT2 and CXCR4 to mediate liver metastasis in colon cancer.
    Cancer Res. 2020 Aug 19. pii: 0008-5472.CAN-19-4028.
    PubMed     Abstract available
    
    
    
35. LUO C, Liang J, Sharabi K, Hatting M, et al
    Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency.
    Cancer Res. 2020;80:3215-3221.
    PubMed     Abstract available
    
    
    
36. ZHANG Y, Cedervall J, Hamidi A, Herre M, et al
    Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis.
    Cancer Res. 2020;80:3345-3358.
    PubMed     Abstract available
    
    
    July 2020
37. MIDORIKAWA Y, Yamamoto S, Tatsuno K, Renard-Guillet C, et al
    Accumulation of molecular aberrations distinctive to hepatocellular carcinoma progression.
    Cancer Res. 2020 Jul 8. pii: 0008-5472.CAN-20-0225.
    PubMed     Abstract available
    
    
    June 2020
38. YANG F, Wei Y, Han D, Li Y, et al
    Interaction with CD68 and regulation of GAS6 expression by endosialin in fibroblasts drives recruitment and polarization of macrophages in hepatocellular carcinoma.
    Cancer Res. 2020 Jun 26. pii: 0008-5472.CAN-19-2691.
    PubMed     Abstract available
    
    
    May 2020
39. CHEN J, Mitra A, Li S, Song S, et al
    Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFbeta Signaling.
    Cancer Res. 2020;80:1819-1832.
    PubMed     Abstract available
    
    
    April 2020
40. ZHANG L, Huo Q, Ge C, Zhao F, et al
    ZNF143-mediated H3K9 trimethylation upregulates CDC6 by activating MDIG in hepatocellular carcinoma.
    Cancer Res. 2020 Apr 20. pii: 0008-5472.CAN-19-3226.
    PubMed     Abstract available
    
    
    March 2020
41. ZHU H, Yan F, Yuan T, Qian M, et al
    USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
    Cancer Res. 2020 Mar 26. pii: 0008-5472.CAN-19-2388.
    PubMed     Abstract available
    
    
    
42. TAN S, Xu Y, Wang Z, Wang T, et al
    Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling.
    Cancer Res. 2020;80:1130-1142.
    PubMed     Abstract available
    
    
    February 2020
43. SCHULIEN I, Hockenjos B, van Marck V, Ayata CK, et al
    Extracellular ATP and Purinergic P2Y2 Receptor Signaling Promote Liver Tumorigenesis in Mice by Exacerbating DNA Damage.
    Cancer Res. 2020;80:699-708.
    PubMed     Abstract available
    
    
    
44. HEBERT JD, Myers SA, Naba A, Abbruzzese G, et al
    Proteomic profiling of the ECM of xenograft breast cancer metastases in different organs reveals distinct metastatic niches.
    Cancer Res. 2020 Feb 4. pii: 0008-5472.CAN-19-2961.
    PubMed     Abstract available
    
    
    
45. LIANG J, Zhao H, Diplas BH, Liu S, et al
    Genome-Wide CRISPR-Cas9 Screen Reveals Selective Vulnerability of ATRX-Mutant Cancers to WEE1 Inhibition.
    Cancer Res. 2020;80:510-523.
    PubMed     Abstract available
    
    
    November 2019
46. ZHOU J, Liu Y, Zhang Y, Li Q, et al
    Modeling tumor evolutionary dynamics to predict clinical outcomes for patients with metastatic colorectal cancer: a retrospective analysis.
    Cancer Res. 2019 Nov 1. pii: 0008-5472.CAN-19-1940.
    PubMed     Abstract available
    
    
    June 2019
47. KAMAL Y, Schmit SL, Hoehn HJ, Amos CI, et al
    Transcriptomic differences between primary colorectal adenocarcinomas and distant metastases reveal metastatic colorectal cancer subtypes.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-18-3945.
    PubMed     Abstract available
    
    
    
48. WANG D, Fu L, Wei J, Xiong Y, et al
    PPARdelta mediates the effect of dietary fat in promoting colorectal cancer metastasis.
    Cancer Res. 2019 Jun 25. pii: 0008-5472.CAN-19-0384.
    PubMed     Abstract available
    
    
    May 2019
49. GORDON JA, Noble JW, Midha A, Derakhshan F, et al
    Upregulation of Scavenger receptor B1 is required for steroidogenic and non-steroidogenic cholesterol metabolism in prostate cancer.
    Cancer Res. 2019 May 7. pii: 0008-5472.CAN-18-2529.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: